Even with all the support and money allocated to the fight against Malaria, AIDS, and Tuberculosis, The Global Fund is taking no chances and continuing to fight the deadly viruses which affect Africa and other Eastern countries. The Global Fund is going to allocate the $17 million to two organizations which are focused on the prevention and care for HIV/AIDS.
The first organization which will be receiving a budget of $11.4 million US dollars is, Key Populations – Representation, Evidence and Attitude Change for Health Impact’ (KP REACH). KP REACH will be focusing on countries which are most affected by HIV: South Africa, Swaziland, Lesotho, Namibia, Zimbabwe, Botswana, Zambia, and Malawi.
The second organization to receive funding is The Kenya AIDS NGO Consortium (KANCO). The organization will be funded $5.5 million US dollars to help with research to help curb the HIV rise.
With drug usage a major concern, and the sharing of needles leading the epidemic. The money is expected to help the spread of dirty needles, as well as deter drug usage as a whole. This initiative is The Global Fund’s attempt to finally eradicate the deadly virus. As they look to fight off Malaria, HIV/AIDS is beginning to take a more prominent role in their eyes due to the numbers of lives being lost daily.
With the recent allocation, officials are hoping to get help from the states which are being given funds to truly take advantage and understand what is at hand.
For more Global Fund information, please visit Scott Filler’s Official website.


The word “Malaria” comes from the 18th century word “mala” which means “bad” and “aria” which means “air.” It wasn’t until 1880 that scientists discovered that Malaria was a disease caused by a parasite which is transmitted by the anopheles mosquito. the mosquito infects the host with a one-cell parasite called plasmodium. By the end of the 18th century, scientists found out that Malaria is transmitted from person-to person through the bite of the female mosquito- which needs blood for her eggs. Approximately 40% of the global population is at risk for the Malaria disease. However, during the 20th century, the disease was effectively eliminated in the majority of non-tropical areas.
The mosquitos that carry the malaria disease from person to person are adapting and therefore becoming resistant to the chemicals in the drugs used to prevent the disease from spreading. This causes scientists to be constantly formulating new drugs in order to save lives for malaria. The writer of the article, Francois Nosten, who is a professor of tropical medicine at the University of Oxford, writes about his time working at the Thai-Myanmar border for 30 years and remembering a time when him and his team believed that malaria was untreatable.The number of people with a particular parasite was declining but the drug that they were using was becoming less effective and more patients were dying.